We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Clobetasol propionate ophthalmic suspension 0.05% was ...
NEW YORK, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Eyenovia (EYEN), Inc. , an ophthalmic technology company, today announced the U.S. launch and commercial availability of clobetasol propionate ophthalmic ...